Search results
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown - ...
Benzinga· 1 hour agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 5 hours agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 12 hours agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 8 hours agoModerna’s Spikevax vaccine was the third jab to be approved for use in the UK in January 2021 after...
Aaron Rodgers Sparks Outrage After Outlandish Claims About U.S. Government, Dr. Anthony Fauci...
Men's Journal via Yahoo News· 6 days agoNew York Jets star Aaron Rodgers has seemingly made as many headlines for his words off the field as...
Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Reuters· 2 weeks ago, opens new tab copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent...
Who can get a Covid booster this spring and how can you book?
BBC via AOL· 1 week agoYou also need to talk to a health professional to check that it is suitable. A protein-based booster...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Were COVID-19 Vaccines to Blame for Infertility? Heart Attacks? A New Report Weighs In
US News & World Report· 1 week agoThe Moderna and Pfizer COVID-19 vaccines can cause myocarditis but evidence suggests they don’t cause infertility, Guillain-Barré syndrome ...
Pfizer's (PFE) RSV Vaccine Study in Adults Under 60 Meets Goal
Zacks via Yahoo Finance· 2 weeks agoPfizer's (PFE) RSV vaccine, Abrysvo, generates an immune response in a phase III study evaluating it...